NCT04316065View on ClinicalTrials.gov

Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 11, 2020

Primary Completion Date

April 20, 2020

Study Completion Date

April 24, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

YHP1906

YHP1906 Tab. 5 mg

DRUG

YHR1902

Comparator. YHR1902 Tab. 5 mg

Trial Locations (1)

14096

Metro Hospital, Anyang-si

All Listed Sponsors
collaborator

Metro Hospital

UNKNOWN

lead

Yuhan Corporation

INDUSTRY

NCT04316065 - Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg | Biotech Hunter | Biotech Hunter